The orphan receptor GPR84 drives inflammation in Buruli ulcer development

expression through Toll-like receptor 2 engagement, promoting proinflammatory cytokine release through a self-amplifying loop that sustained receptor expression and inflammatory signaling. Moreover, pharmacological inhibition of GPR84 with the antagonist PBI-4050, in combination with antibiotics, accelerated tissue repair in infected GPR84-competent mice, which was associated with attenuation of inflammatory responses. Together, these findings establish GPR84 as a promising target for host-directed therapeutic interventions in Buruli ulcer and its expression as a potential biomarker of lesion activity.

Authors

Institutions

Publication Details

Journal
Science Translational Medicine
Published
2026-04-15
DOI
https://doi.org/10.1126/scitranslmed.ads8681
Primary Topic
Mycobacterium research and diagnosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The orphan receptor GPR84 drives inflammation in Buruli ulcer development

Line Ganlonon, Florian Tarnaud, Étienne Meunier, João Fevereiro et al.
Science Translational Medicine
Mycobacterium research and diagnosis
article

The orphan receptor GPR84 drives inflammation in Buruli ulcer development

Line Ganlonon, Florian Tarnaud, Étienne Meunier, João Fevereiro, Nathalie Labarrière, Laurent Marsollier, Ambroise Adeye, Pascale Pignon, Marie Robbe-Saule, Jorge Pedrosa, Vincent Dubée, Nicolas Gouault, Alexandra G. Fraga, Guillaume Lebon, Aurélie Sauvager, Priscille Brodin, Marianne Lafont, Mélanie Foulon, Estelle Marion, Edouard Yeramian, Ivo Gomperts Boneca, Laurence Touami, Ludovic Martin, Anne Croué
article en

Abstract

expression through Toll-like receptor 2 engagement, promoting proinflammatory cytokine release through a self-amplifying loop that sustained receptor expression and inflammatory signaling. Moreover, pharmacological inhibition of GPR84 with the antagonist PBI-4050, in combination with antibiotics, accelerated tissue repair in infected GPR84-competent mice, which was associated with attenuation of inflammatory responses. Together, these findings establish GPR84 as a promising target for host-directed therapeutic interventions in Buruli ulcer and its expression as a potential biomarker of lesion activity.

Science Translational MedicineVol. 18(845)
University of Geneva (CH), Centre National de la Recherche Scientifique (FR), Inserm (FR), Institut Pasteur (FR), Université Fédérale de Toulouse Midi-Pyrénées (FR), Université Paris Cité (FR), Centre Hospitalier Universitaire de Lille (FR), Université Rennes 2 (FR), Institut des Sciences Chimiques de Rennes (FR), Ministère de la Santé (TN), Center for Infection and Immunity of Lille (FR), Toulouse Mathematics Institute (FR), Centre Hospitalier Universitaire d'Angers (FR), Institut de Génomique Fonctionnelle (FR), Nutrition, métabolismes et cancer (FR), Université d'Angers (FR), Université de Rennes (FR), Nantes Université (FR), University of Minho (PT)
Fondation pour la Recherche Médicale, Société Française de Dermatologie et de Pathologie Sexuellement Transmissible, Universite Angers, Conseil Régional des Pays de la Loire, Fondation Raoul Follereau
Good health and well-being
Openalex Percentile: Top 25%
Mycobacterium research and diagnosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.